Showing results (1421-1430 of 1,614) with videos related to

Sort By:
Pageof 162
RSC Medicinal Chemistry|March 17, 2025
Development of p300-targeting degraders with enhanced selectivity and onset of degradationGraham P Marsh, Mark S Cooper, Sean Goggins, et al.
RSC Medicinal Chemistry|October 21, 2024
Semisynthetic phytochemicals in cancer treatment: a medicinal chemistry perspectiveMeghna Arora, Ankit Kumar Singh, Adarsh Kumar, et al.
RSC Medicinal Chemistry|October 18, 2024
Correction: computational design, synthesis, and assessment of 3-(4-(4-(1,3,4-oxadiazol-2-yl)-1H-imidazol-2-yl)phenyl)-1,2,4-oxadiazole derivatives as effective epidermal growth factor receptor inhibitors: a prospective strategy for anticancer therapyNilesh Raghunath Khedkar, Milind Sindkhedkar, Alex Joseph
RSC Medicinal Chemistry|October 18, 2024
Rapid identification of novel indolylarylsulfone derivatives as potent HIV-1 NNRTIs via miniaturized CuAAC click-chemistry-based combinatorial librariesPing Gao, Shu Song, Christophe Pannecouque, et al.
RSC Medicinal Chemistry|October 7, 2024
Repurposing of USFDA-approved drugs to identify leads for inhibition of acetylcholinesterase enzyme: a plausible utility as an anti-Alzheimer agentKapil Kumar Goel, Sandhya Chahal, Devendra Kumar, et al.
RSC Medicinal Chemistry|October 4, 2024
Unveiling the anticancer potential of plumbagin: targeting pyruvate kinase M2 to induce oxidative stress and apoptosis in hepatoma cellsJun Wu, Zhenjiang Ding, Jingwen Tu, et al.
RSC Medicinal Chemistry|October 7, 2024
Inhibition of SARS-CoV-2 3CLpro by chemically modified tyrosinase from Agaricus bisporusDavid Aguilera-Rodriguez, David Ortega-Alarcon, Angela Vazquez-Calvo, et al.
RSC Medicinal Chemistry|October 7, 2024
Strong in vitro anticancer activity of copper(ii) and zinc(ii) complexes containing naturally occurring lapachol: cellular effects in ovarian A2780 cellsSara Stocchetti, Ján Vančo, Jan Belza, et al.
RSC Medicinal Chemistry|September 9, 2024
In vitro identification of oridonin hybrids as potential anti-TNBC agents inducing cell cycle arrest and apoptosis by regulation of p21, γH2AX and cleaved PARPJinhua Ning, Nini Zhan, Zhanpan Wu, et al.
RSC Medicinal Chemistry|September 9, 2024
Synthesis of a celastrol derivative as a cancer stem cell inhibitor through regulation of the STAT3 pathway for treatment of ovarian cancerMeijuan Liu, Na Li, Zhaoxue Wang, et al.
Pageof 162